ArticleFrontiers in medicine2021

Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial.

Yan Press et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.